AC Immune
ACIU
41 hedge funds and large institutions have $90.6M invested in AC Immune in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 14 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
5% more funds holding
Funds holding: 39 → 41 (+2)
3.52% less ownership
Funds ownership: 30.06% → 26.54% (-3.5%)
53% less capital invested
Capital invested by funds: $191M → $90.6M (-$101M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$33.2M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$4.52M |
| 3 |
AG
Artal Group
Luxembourg
|
+$1.59M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$1.14M |
| 5 |
Millennium Management
New York
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$22.4M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$14.9M |
| 3 |
O
OrbiMed
New York
|
-$13.6M |
| 4 |
DFO
Duquesne Family Office
New York
|
-$7.42M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$4.5M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
QSS
51
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
| – | -$102K | -10,757 | Closed |
|
52
Barclays
London,
United Kingdom
| – | -$61K | -6,378 | Closed |
|
53
Bank of America
Charlotte,
North Carolina
| – | -$19.9K | -3,131 | -100% |
|
54
Daiwa Securities Group
Tokyo,
Japan
| – | -$6K | -600 | Closed |
|
ACIU Hedge Fund Activity: Q1 2019 in Review
41 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q1 2019, worth a combined $90.6M — down 53% from $191M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ACIU positions and 14 closed out — a net gain of 2 holders — while 14 added to existing stakes and 6 trimmed.
The largest buyer was BVF Inc, adding an estimated $33.2M. The largest seller was Fidelity Investments, cutting an estimated $22.4M.
- 41 institutional investors held AC Immune (ACIU) as of Q1 2019, up from 39 in Q4 2018.
- Funds reported $90.6M of AC Immune stock for Q1 2019, down 53% quarter-over-quarter.
- 16 funds opened new AC Immune positions in Q1 2019 and 14 closed out, a net change of +2 holders.
- The largest AC Immune buyer in Q1 2019 was BVF Inc, an estimated $33.2M added.
- The largest AC Immune seller in Q1 2019 was Fidelity Investments, an estimated $22.4M sold.
Based on aggregated 13F filings for Q1 2019.